Shanghai INT Medical Instruments Co., Ltd. Class H

As of December 31, 2025, Shanghai INT Medical Instruments Co., Ltd. Class H carries a market capitalization of 5.22B, placing it among publicly traded companies globally. Its enterprise value stands at 5.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Shanghai INT Medical Instruments Co., Ltd. Class H's next confirmed earnings release is scheduled for March 22, 2027.

As of December 31, 2025, Shanghai INT Medical Instruments Co., Ltd. Class H has 174.25M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Shanghai INT Medical Instruments Co., Ltd. Class H maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Shanghai INT Medical Instruments Co., Ltd. Class H's stock has declined approximately 1.69% over the past 52 weeks. The 50-day moving average sits at 33.39, while the 200-day moving average is 32.99.

As of December 31, 2025, Shanghai INT Medical Instruments Co., Ltd. Class H holds 702.02M in cash and equivalents against 796.78M in total debt, resulting in a net debt position of 87.99M. Total book value stands at 2.22B, with working capital of 236.25M providing operational flexibility.